Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective

SIMPLE SUMMARY: Despite recent progress in the treatment of metastatic colorectal cancer patients, novel therapeutic approaches are highly warranted to further improve outcome. Additionally, it is of utmost importance to define subgroups of patients who may derive the most benefit from a specific tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Puccini, Alberto, Seeber, Andreas, Berger, Martin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564318/
https://www.ncbi.nlm.nih.gov/pubmed/36230751
http://dx.doi.org/10.3390/cancers14194828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564318/
https://www.ncbi.nlm.nih.gov/pubmed/36230751
http://dx.doi.org/10.3390/cancers14194828

Ejemplares similares